Bristol Myers Squibb Rating Increased to Buy at Bank of America (BMY)
Shares of Bristol Myers Squibb opened at 37.57 on Monday. Bristol Myers Squibb has a 52 week low of $30.64 and a 52 week high of $37.60. The stock’s 50-day moving average is currently $36.28. The company has a market cap of $61.515 billion and a P/E ratio of 32.39.
BMY has been the subject of a number of other recent research reports. Analysts at TheStreet reiterated a buy rating on shares of Bristol Myers Squibb in a research note to investors on Monday. Separately, analysts at Cowen reiterated an outperform rating on shares of Bristol Myers Squibb in a research note to investors on Tuesday, February 19th. Finally, analysts at Jefferies Group raised their price target on shares of Bristol Myers Squibb from $39.00 to $41.00 in a research note to investors on Tuesday, February 12th. They now have a buy rating on the stock.
Five equities research analysts have rated the stock with a buy rating, one has assigned an overweight rating, fourteen have issued a hold rating, and one has issued a sell rating to the company. The stock has an average rating of hold and a consensus target price of $35.46.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.